Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00720304
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 43
Not applicableStudy completedNCT01487733
What this trial is testing

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 155
Testing effectiveness (Phase 2)Study completedNCT02608073
What this trial is testing

Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Hoffmann-La Roche 45
Testing effectiveness (Phase 2)Study completedNCT04350190
What this trial is testing

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 25
Testing effectiveness (Phase 2)UnknownNCT05981157
What this trial is testing

Anrotinib and Tirelizumab in First-line Treatment of RM-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China 27
Testing effectiveness (Phase 2)Study completedNCT00436800
What this trial is testing

Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sanofi 41
Large-scale testing (Phase 3)Study completedNCT00017511
What this trial is testing

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Daiichi Sankyo
Large-scale testing (Phase 3)UnknownNCT02944708
What this trial is testing

Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 384
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138989
What this trial is testing

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 10
Testing effectiveness (Phase 2)Study completedNCT00003850
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)UnknownNCT01347424
What this trial is testing

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Who this might be right for
Non Small Cell Lung CancerNasopharyngeal CancerLiver Metastasis
Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT03648697
What this trial is testing

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07038343
What this trial is testing

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+5 more
Avenzo Therapeutics, Inc. 480
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07320963
What this trial is testing

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 52
Testing effectiveness (Phase 2)Study completedNCT01392235
What this trial is testing

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Recurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 58
Testing effectiveness (Phase 2)Study completedNCT00006033
What this trial is testing

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)UnknownNCT04421469
What this trial is testing

Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 39
Testing effectiveness (Phase 2)Study completedNCT01349933
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the NasopharynxStage IV Squamous Cell Carcinoma of the Nasopharynx
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Looking for participantsNCT06839066
What this trial is testing

A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech 70
Next Page